GammaDelta - Ownership and Business Overview

Life ScienceCompany

GammaDelta Ownership

Who owns GammaDelta?

GammaDelta is owned by Takeda Pharmaceutical. It was acquired on October 27, 2021.

GammaDelta Business Overview

Where is GammaDelta headquartered?

GammaDelta is headquartered in London, United Kingdom.

What sector is GammaDelta in?

GammaDelta is a life science company.

When was GammaDelta founded?

GammaDelta was founded in 2016.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Subscribe to Mergr to view all 400 acquisitions of life science companies in 2021, including 47 acquisitions by private equity firms, and 353 by strategics.

GammaDelta

GammaDelta Therapeutics Ltd.

The WestWorks, 195 Wood Lane, White City Place,
London, W12 7FQ
United Kingdom,
+44 (0) 208 051 6710
www.gammadeltatx.com

GammaDelta is a clinically-staged biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer. Committed to transforming the treatment of patients living with cancer, the Company is developing an ‘off-the-shelf’ therapy based on one of the body’s own immune cells, a subtype of the gamma delta (γδ) T-lymphocyte, known as the Vδ1+ T cell. GammaDelta was founded in 2016 and is based in London, England.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for GammaDelta

Life Science Companies